Work

Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Previously Treated with Ibrutinib (CITADEL-205)

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-134609

Authors: Pier Luigi Zinzani, Vincent Delwail, Shankara Paneesha, Simon Rule, Alejandro Martin Garcia-Sancho, Ana Marin-Niebla, Gilles Salles, Juan-Manuel Sancho, Vibeke Vergote, Vittorio Ruggero Zilioli, Fred Zheng, Douglas J DeMarini, Wei Jiang, Amitkumar Mehta

Institutions: University of Bologna, Centre Hospitalier Universitaire de Poitiers, Heartlands Hospital, University Hospitals Plymouth NHS Trust, Instituto de Investigación Biomédica de Salamanca, Vall d'Hebron Hospital Universitari, Hospices Civils de Lyon, Hospital Universitari Germans Trias i Pujol, Universitair Ziekenhuis Leuven, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Incyte (United States), University of Alabama at Birmingham, UAB Medicine

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4231622124

FWCI: 1.61

Cites:

Cited by: 11

Related to: 10